Tucatinib (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Tucatinib" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
low place
low place
3,984th place
5,225th place
cancernetwork.com (Global: low place; Portuguese: low place)
- «ONT-380 Active Against CNS Mets in HER2-Positive Breast Cancer». Cancer Network. 15 de dezembro de 2015. Consultado em 17 de abril de 2020[ligação inativa]
doi.org (Global: 2nd place; Portuguese: 4th place)
dx.doi.org
- Martin M, López-Tarruella S (outubro de 2018). «Emerging Therapeutic Options for HER2-Positive Breast Cancer». American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 35 (36): e64–70. PMID 27249772. doi:10.1200/EDBK_159167
fda.gov (Global: 447th place; Portuguese: 869th place)
- «FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer». U.S. Food and Drug Administration (FDA) (Nota de imprensa). 17 de abril de 2020. Consultado em 17 de abril de 2020
Este artigo incorpora texto desta fonte, que está no domínio público. - «FDA approves tucatinib for patients with HER2-positive metastatic brea». U.S. Food and Drug Administration (FDA). 17 de abril de 2020. Consultado em 20 de abril de 2020 Este artigo incorpora texto desta fonte, que está no domínio público.
nih.gov (Global: 4th place; Portuguese: 8th place)
ncbi.nlm.nih.gov
- Martin M, López-Tarruella S (outubro de 2018). «Emerging Therapeutic Options for HER2-Positive Breast Cancer». American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 35 (36): e64–70. PMID 27249772. doi:10.1200/EDBK_159167
tga.gov.au (Global: 3,984th place; Portuguese: 5,225th place)
- «Tukysa». Therapeutic Goods Administration (TGA). 21 de agosto de 2020. Consultado em 22 de setembro de 2020